Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseases

This article was originally published here

As part of single target research collaboration, both companies will conduct research activities to select a pre-clinical candidate after which Roche will focus on further development and global

The post Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseases appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply